enVVeno Medical Corporation is a medical device company. It focuses in the treatment of venous disease. enVVeno Medical Corporation, formerly known as Hancock Jaffe Laboratories Inc., is based in IRVINE, CA.
| Revenue (Most Recent Fiscal Year) | -- |
| Net Income (Most Recent Fiscal Year) | $-21.82M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | -- |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.27 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -- |
| Net Margin (Trailing 12 Months) | -- |
| Return on Equity (Trailing 12 Months) | -61.45% |
| Return on Assets (Trailing 12 Months) | -56.88% |
| Current Ratio (Most Recent Fiscal Quarter) | 13.12 |
| Quick Ratio (Most Recent Fiscal Quarter) | 13.12 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $2.40 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.23 |
| Earnings per Share (Most Recent Fiscal Year) | $-1.27 |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.08 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 20.22M |
| Free Float | 17.18M |
| Market Capitalization | $7.84M |
| Average Volume (Last 20 Days) | 0.90M |
| Beta (Past 60 Months) | 1.06 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 15.00% |
| Percentage Held By Institutions (Latest 13F Reports) | 34.71% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |